OTUD6B and neoplasm: Similarly, in ccRCC tumor cells with pVHL missense mutations, OTUD6B inhibited ccRCC migration by regulating pVHL/HIF-2α; low levels of OTUD6B predicted a higher pathological stage and shorter OS in ccRCC patients [94] (Fig. 7).